After years of negotiations, several major drug distributors have proposed a settlement to resolve claims they contributed to the opioid crisis.
Small businesses, schools and enthusiasts used 3D printers to make millions of PPE products last year, but the technology may be too slow to make a big difference going forward.
Medical gloves and gowns in the U.S. have been in short supply during the pandemic. Now HHS is researching ways to expand domestic production.
Makers of PPE and test kits are laying off hundreds of workers as the demand for their products drop.
The pandemic forced researchers to incorporate remote elements into clinical trials. Now, that’s becoming routine and logistics companies are stepping up to make it possible.
Lockdown measures are slowing production of medical gloves in Malaysia, which produces the vast majority of the world’s supply. The use of forced labor and a lack of domestic U.S. production could mean shortages will continue into 2022.
The story behind shortages of two skin disinfectant products is a parable about the challenges facing medical supply chains right now.
A group of U.S. mask manufacturers is calling on the federal government to buy their products to prevent the industry from collapsing.
Amid calls to produce more drugs in the U.S., a startup has raised $73 million to produce drug components from engineered yeast.
The agency used regulatory flexibility and expedited reviews extensively to prevent drug shortages in 2020.
A Seattle-based startup aiming to give health care providers an easier way to get medical supplies recently raised $1.5 million in seed funding to expand its business.
Device makers ask the federal government for help getting shipments through crowded ports, but it’s not clear how that would work.
An increase in elective surgeries and accidents is increasing demand for blood in the U.S., leading to severe shortages, according to a Red Cross report.
A new tech transfer hub in South Africa aims to increase access to COVID-19 vaccines in countries that have struggled to get shots.
A problematic Emergent vaccine plant in Maryland still lacks approval, even after FDA declared some doses produced there are safe to use.
Incentives for manufacturers and more supply chain visibility could help reduce shortages, according to a new White House report.
The details are murky, but the decision to remove priority ratings under the Defense Production Act may not change much about the vaccines supply chain.
A group of private equity firms signed a deal, reportedly worth $30 billion, for a majority stake in the private medical distributor Medline.
The Strategic National Stockpile is asking Congress for more money to build back its inventory following the COVID-19 pandemic, but it’s already starting to make improvements to day-to-day operations.
The FDA is asking Congress to fund new programs focused on regulating the health care supply chain and mitigating shortages.
